Institutional Ownership Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 395,469 shares, which have been reported (via 13F filing form) to have a value of $71,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
160,000
shares
|
$28,800
0.28% of portfolio
|
Q4 2021
New holding
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
86,753
shares
|
$15,615
0.0% of portfolio
|
Q3 2023
Reduced 1.12%
|
|
|
Clear Street LLC
|
May 13, 2024 Q1 2024 |
59,172
shares
|
$10,650
0.0% of portfolio
|
Q1 2024
Reduced 0.17%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
48,138
shares
|
$8,664
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Warberg Asset Management LLC
Winnetka, IL |
May 06, 2024 Q1 2024 |
41,406
shares
|
$7,453
0.12% of portfolio
|
Q1 2024
Reduced 34.8%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Apr 30, 2024 Q1 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|